SCHEMBL9000768

SCHEMBL9000768

COc1ccc(CSC(C(=O)Nc2c(SC)cc(C)nc2SC)c2ccc(Cl)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 1/20 0.41
▸ CNR2 P34972 1/20 0.39
▸ ABL1 P00519 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ KLK7 P49862 4/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ FPR2 P25090 1/20 0.35
▸ UTS2R Q9UKP6 1/20 0.35
▸ FNTA P49354 1/20 0.35
▸ FNTB P49356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9000729 1.00 EPHX1 (0.41) EPHX1CNR2ABL1SRCMAPT
SCHEMBL9000423 0.95 EPHX1 (0.44) EPHX1MAPTSMN1; SMN2LMNAMMP13
SCHEMBL9000777 0.94 KMT2A (0.37) CNR2LMNACYP1A2CYP3A4
SCHEMBL9000708 0.91 EPHX1 (0.38) EPHX1MAPTSMN1; SMN2LMNAMMP13
SCHEMBL9000878 0.91 EPHX1 (0.41) EPHX1ABL1SRCMAPTSMN1; SMN2
SCHEMBL9000458 0.91 EPHX1 (0.41) EPHX1ABL1SRCMAPTSMN1; SMN2
SCHEMBL9000398 0.91 EPHX1 (0.47) EPHX1CNR2MAPTSMN1; SMN2LMNA
SCHEMBL9000831 0.91 TOP2A (0.37) MAPTSMN1; SMN2LMNA
SCHEMBL9000898 0.90 EPHX1 (0.46) EPHX1MAPTL3MBTL1CYP3A4ALDH1A1
SCHEMBL9000497 0.89 EPHX1 (0.38) EPHX1ABL1SRCMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5583147-A INHIBITORS OF ACYL-COENZYME A: CHOLESTEROL O-TRANSFERASE; ANTIHYPERCHOLESTEROLEMIC AND/OR ANTIATHEROSCLEROTIC AGENTS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-10 — — US disclosed
Send feedback